FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

McCaskill: Americans Pay More Than International Patients for Common Part D Drugs

Nov. 9, 2018
A A

Sen. Claire McCaskill (D-Mo.) released a third report on drug pricing claiming her constituents pay up to 600 percent more than citizens of other countries for branded Medicare Part D drugs.

McCaskill’s office gathered drug pricing data from pharmacies in and around Missouri, the Organisation for Economic Cooperation and Development and European, Mexican and Canadian regulatory agencies.

On average, Missourians paid between 166 percent and 591 percent more than people in Italy, France and Canada for 65 percent of the 20 most commonly-prescribed brand name Part D drugs.

View today's stories